Literature DB >> 10771040

Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.

G R King1, Z Xiong, S Douglass, E H Ellinwood.   

Abstract

Intermittent cocaine administration induces sensitization (reverse tolerance) to its behavioral effects. The mechanism(s) mediating sensitization is not clear, however, previous research has implicated 5-HT(3) receptors in the expression of sensitization. The present experiment evaluated the ability of the 5-HT(3) receptor antagonist, ondansetron, administered during withdrawal from chronic intermittent cocaine administration, to block the expression of sensitization. Rats were pretreated for 14 days by daily subcutaneous injections of either 40 mg/kg cocaine or 0.9% saline. During the first 5 days of withdrawal from this pretreatment regimen, all rats received a daily subcutaneous injection of 0-1.0 mg/kg ondansetron. On days 7, 14 or 28 of withdrawal from the cocaine pretreatment, the rats received a 15.0-mg/kg cocaine challenge. Ambulatory behavior was automatically recorded for 60 min. Ondansetron had no significant effect on the subsequent behavioral response to cocaine in the saline control subjects. In contrast, daily injections of ondansetron blocked the expression of sensitization at all withdrawal times. We thus report that it is possible to permanently block the expression of sensitization once it has developed by administering a 5-HT(3) receptor antagonist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771040     DOI: 10.1016/s0014-2999(99)00926-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

Review 2.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

3.  Differences in regional cerebral blood flow response to a 5HT3 antagonist in early- and late-onset cocaine-dependent subjects.

Authors:  Bryon Adinoff; Michael D Devous; Mark J Williams; Thomas S Harris; Susan E Best; Hongyun Dong; Tanya Zielinski
Journal:  Addict Biol       Date:  2012-03-28       Impact factor: 4.280

Review 4.  Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside.

Authors:  Steven M Graves; Roueen Rafeyan; Jeffrey Watts; T Celeste Napier
Journal:  Pharmacol Ther       Date:  2012-08-29       Impact factor: 12.310

5.  Ifenprodil Attenuates Methamphetamine-Induced Behavioral Sensitization and Activation of Ras-ERK-∆FosB Pathway in the Caudate Putamen.

Authors:  Lu Li; Xinshe Liu; Chuchu Qiao; Gang Chen; Tao Li
Journal:  Neurochem Res       Date:  2016-06-23       Impact factor: 3.996

6.  Early ontogeny of D-amphetamine-induced one-trial behavioral sensitization.

Authors:  Sanders A McDougall; Charlotte M Nuqui; Anthony T Quiroz; Carrissa M Martinez
Journal:  Pharmacol Biochem Behav       Date:  2013-01-27       Impact factor: 3.533

7.  Dorsal raphe neuronal activities are modulated by methylphenidate.

Authors:  Bin Tang; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2012-12-27       Impact factor: 3.575

8.  A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.

Authors:  Derek Blevins; Chamindi Seneviratne; Xin-Qun Wang; Bankole A Johnson; Nassima Ait-Daoud
Journal:  Drug Alcohol Depend       Date:  2021-09-24       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.